| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/08/2002 | US20020107220 By replication of the nucleic acids of the viruses in that distribution by use of a defective replication system; virus population lose pathogenic properties, infectiousness; treating viral diseases |
| 08/08/2002 | US20020106799 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106641 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/08/2002 | US20020106379 Viral vaccines based on the engineered viruses |
| 08/08/2002 | CA2437072A1 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228199A2 Method for directed packaging of molecular substances in protein shells |
| 08/07/2002 | EP1228196A1 Method for purifying aav |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | CN1362885A AIDS virus vaccine with use of sendai virus vector |
| 08/07/2002 | CN1088598C Culture process of high-yield weak-toxicity distemper cell strain |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429001 Recombinant AAV packaging systems |
| 08/06/2002 | US6428988 (aav); first cre recombinase vector, second vector contains a promoter, spacer sequence flanked by loxp sites and rep/cap, and third vector containing a transgene and regulatory sequences flanked by aav inverted terminal repeats (itr) |
| 08/06/2002 | US6428953 Retrovirus vectors; plasmids; gene delivery; genetic engineering; human immunodeficiency virus |
| 08/01/2002 | WO2002059321A2 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | WO2002042480A3 Modified vaccinia ankara virus variant |
| 08/01/2002 | WO2002004019A3 Use of strains of the parapox ovis virus against organ fibrosis |
| 08/01/2002 | WO2001092551A3 Duplexed parvovirus vectors |
| 08/01/2002 | WO2001077157A3 Full-length gb virus c (hepatitis g virus) rna transcripts are infectious in primary cd4 positive t cells and methods of treating hiv |
| 08/01/2002 | WO2001027301A9 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103144 Retroviral gene transfer vectors |
| 08/01/2002 | US20020102714 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/01/2002 | US20020102674 Porous structure for use in generation of control release membranes |
| 08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102536 Preparation of human or animal herpesviruses |
| 08/01/2002 | US20020102529 Storage and maintenance of blood products including red blood cells and platelets |
| 08/01/2002 | CA2434845A1 Hepatitis c virus replicons and replicon enhanced cells |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 07/31/2002 | EP1226169A2 Molecular structure of rhd negative locus |
| 07/31/2002 | EP1225923A1 Method of inactivating pathogens |
| 07/31/2002 | EP0631633B1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 07/31/2002 | CN1361824A Porcine circovirus recombinant poxvirus vaccine |
| 07/30/2002 | US6426196 Alphavirus structural protein expression cassettes |
| 07/30/2002 | US6426073 Genetic engineered polypeptides |
| 07/30/2002 | CA2084673C 16 kda surface protein of p.falciparum |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002057314A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002056828A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/25/2002 | US20020100066 Negative strand rna viral vector having autonomous replication capability |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020098576 Recombinant sendai virus |
| 07/25/2002 | US20020098571 Plasmid for use as tool in genetic engineering |
| 07/25/2002 | US20020098202 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
| 07/25/2002 | US20020098170 Herpes simplex virus type 1 ( HSV-1)-derived vector for selectively inhibiting maligant cells and methods for its use to treat cancer and to express desired traits in maligant and non-miligant mammalian cells |
| 07/25/2002 | US20020098165 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/25/2002 | US20020098123 Liquid withdrawing tray for purification column, purification column, and method for purification |
| 07/25/2002 | DE10104094C1 Increasing viral replication and yield in cell cultures, useful e.g. for detecting residual hepatitis A in inactivated products, by blocking activation of RNaseL |
| 07/25/2002 | DE10056059A1 Differenzierung auslösende Substanzen Differentiation-inducing substances |
| 07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2430589A1 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/24/2002 | EP1225229A1 Gene transfer method |
| 07/24/2002 | EP1224314A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 07/24/2002 | EP1224313A1 Adeno-associated viruses and uses thereof |
| 07/24/2002 | EP1224312A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 07/24/2002 | EP1224311A1 Recombinant, replication defective celo virus and celo virus dna |
| 07/24/2002 | EP1224310A1 Recombinant adenoviruses preparation and adenovirus banks |
| 07/24/2002 | EP1224301A2 Methods and compositions for targeting a cell |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1223976A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 07/24/2002 | EP0938679B1 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 07/24/2002 | EP0687184B1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 07/24/2002 | EP0674497B1 Microporous macrocapsules |
| 07/23/2002 | US6423528 Herpes simplex virus-1 strain 17, genome of which is modified in specified terminal portion such that strain lacks neurovirulence |
| 07/23/2002 | US6423516 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 07/23/2002 | US6423318 Hepatitis A virus vaccines |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002054873A2 Microbiological agents for the control of sea lice |
| 07/18/2002 | WO2002033129A3 Nucleic acid amplification controls |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | US20020094337 Prevention of recurrent viral disease |
| 07/18/2002 | US20020094324 Gene therapy for restenosis using an adenoviral vector |
| 07/18/2002 | CA2434548A1 Microbiological agents for the control of sea lice |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222299A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 07/17/2002 | EP1222281A2 Immunoligically significant herpes simplex virus antigens |
| 07/17/2002 | EP1222254A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 07/17/2002 | CN1359391A 重组腺病毒 Recombinant adenovirus |
| 07/17/2002 | CN1359388A Method for enhanced protein stabilization and production of cell liell lines useful for production of such stabilized proteins |
| 07/17/2002 | CN1087777C Human embryonic Iung fibroblast diploid cell strain suitable for production of virus and process for production of varicella zoster virus using same |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | CA2124580C Method for selecting recombinant microorganisms containing at their surface at least one molecule having enzymatic activity |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053712A2 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |